相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase
Rameez Jabeer Khan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Crystal structure of SARS-CoV-2 papain-like protease
Xiaopan Gao et al.
ACTA PHARMACEUTICA SINICA B (2021)
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors**
Kai S. Yang et al.
CHEMMEDCHEM (2021)
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
Hongbo Liu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
Jia-Tsrong Jan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery
Ziyang Fu et al.
NATURE COMMUNICATIONS (2021)
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
Kirill Gorshkov et al.
ACS INFECTIOUS DISEASES (2021)
Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin
Wanchao Yin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
Bepridil is potent against SARS-CoV-2 in vitro
Erol C. Vatansever et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Kris M. White et al.
SCIENCE (2021)
Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets
Rory D. de Vries et al.
SCIENCE (2021)
SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model
Jingxin Qiao et al.
SCIENCE (2021)
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2
Hanjun Zhao et al.
NATURE COMMUNICATIONS (2021)
The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract
Yuejun Shi et al.
EMERGING MICROBES & INFECTIONS (2021)
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses
Yanmei Hu et al.
ACS INFECTIOUS DISEASES (2021)
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms
Ana C. Puhl et al.
ACS OMEGA (2021)
Antivirals with common targets against highly pathogenic viruses
Lu Lu et al.
CELL (2021)
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
Shuofeng Yuan et al.
NATURE (2021)
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
Sho Iketani et al.
NATURE COMMUNICATIONS (2021)
Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
C. Joaquin Caceres et al.
SCIENTIFIC REPORTS (2021)
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
Jordi Rodon et al.
FRONTIERS IN PHARMACOLOGY (2021)
Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein- Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
Damir Bojadzic et al.
ACS INFECTIOUS DISEASES (2021)
Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis
Deep Bhowmik et al.
HELIYON (2021)
Inhibitors of thiol-mediated uptake
Yangyang Cheng et al.
CHEMICAL SCIENCE (2021)
The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection
Brandon J. Beddingfield et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Yuling Han et al.
NATURE (2021)
Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle
Yingying Cong et al.
JOURNAL OF VIROLOGY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Shuai Xia et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV
Jared S. Morse et al.
CHEMBIOCHEM (2020)
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
David Gurwitz
DRUG DEVELOPMENT RESEARCH (2020)
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Potential interventions for novel coronavirus in China: A systematic review
Lei Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
A distinct name is needed for the new coronavirus
Shibo Jiang et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
Yanxiao Han et al.
ACS NANO (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
Sen Liu et al.
BIOINFORMATICS (2020)
The Architecture of SARS-CoV-2 Transcriptome
Dongwan Kim et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
N. Lian et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection
Du Yin-Xiao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections
Robert C. Speth
DRUG DEVELOPMENT RESEARCH (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment
Sandra P. Smieszek et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein
Naveen Vankadari
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Teicoplanin: an alternative drug for the treatment of COVID-19?
Sophie Alexandra Baron et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Favipiravir, an antiviral for COVID-19?
Eric A. Coomes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng et al.
JOURNAL OF INFECTION (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Yan Gao et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA
Jose Antonio Encinar et al.
VIRUSES-BASEL (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Potential of heparin and nafamostat combination therapy for COVID-19
Hidesaku Asakura et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity
Yuanmei Zhu et al.
JOURNAL OF VIROLOGY (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
The COVID-19 pandemic and the use of MS disease-modifying therapies
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Characterization and Noncovalent Inhibition of the Deubiquitinase and delSGylase Activity of SARS-CoV-2 Papain-Like Protease
Brendan T. Freitas et al.
ACS INFECTIOUS DISEASES (2020)
Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan
Li Ni et al.
FRONTIERS OF MEDICINE (2020)
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
Richard T. Eastman et al.
ACS CENTRAL SCIENCE (2020)
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
Sisi Kang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
Xiaoyan Liu et al.
ACTA PHARMACEUTICA SINICA B (2020)
A new coronavirus associated with human respiratory disease in China (vol 579, pg 265, 2020)
Fan Wu et al.
NATURE (2020)
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Denisa Bojkova et al.
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
Xi Wang et al.
CELL DISCOVERY (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
Zhenming Jin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a Case Report and Review of ABL Kinase Involvement in Viral Infection
Elisabetta Abruzzese et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission-A Preliminary Report of a Retrospective Cohort Study
Jin-nong Zhang et al.
CURRENT MEDICAL SCIENCE (2020)
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
Ashley Barlow et al.
PHARMACOTHERAPY (2020)
Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle
Clarisse Salgado-Benvindo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
Severe COVID-19 infection in a patient with multiple sclerosis treated with fi ngolimod
Christian Foerch et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial
Ke Hu et al.
VIROLOGICA SINICA (2020)
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle et al.
LIFE SCIENCE ALLIANCE (2020)
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
Abdo A. Elfiky
LIFE SCIENCES (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
Markus Hoffmann et al.
NATURE (2020)
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
Laura Riva et al.
NATURE (2020)
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
Pauline Maisonnasse et al.
NATURE (2020)
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
Li Runfeng et al.
PHARMACOLOGICAL RESEARCH (2020)
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2
Theresa Klemm et al.
EMBO JOURNAL (2020)
Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
Yuan-Lin Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice
Athri D. Rathnayake et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
Mizuki Yamamoto et al.
VIRUSES-BASEL (2020)
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
Franck Touret et al.
SCIENTIFIC REPORTS (2020)
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
Rui Xiong et al.
PROTEIN & CELL (2020)
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
Stuart Weston et al.
JOURNAL OF VIROLOGY (2020)
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Longxing Cao et al.
SCIENCE (2020)
GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
Shin-ichiro Hattori et al.
MBIO (2020)
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
Lifeng Fu et al.
NATURE COMMUNICATIONS (2020)
A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2
Hanjun Zhao et al.
NATURE COMMUNICATIONS (2020)
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Wayne Vuong et al.
NATURE COMMUNICATIONS (2020)
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects
Ya-Wen Cheng et al.
CELL REPORTS (2020)
Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs
Valentina L. Kouznetsova et al.
PEERJ (2020)
Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease
Muhammad Usman Mirza et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)
High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents
Phongthon Kanjanasirirat et al.
SCIENTIFIC REPORTS (2020)
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
Wei Zhu et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
Catherine Z. Chen et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
Chunlong Ma et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L
Michael Dominic Sacco et al.
SCIENCE ADVANCES (2020)
Baicalein inhibits SARS-CoV-2/VSV replication with interfering mitochondrial oxidative phosphorylation in a mPTP dependent manner
Shichao Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2
Zhe-Rui Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein
Chan Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet et al.
LANCET RHEUMATOLOGY (2020)
Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS) Protocol for a Pragmatic, Open-Label, Active Comparator Trial
Samuel M. Brown et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)
Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors
Nashwa Hafez Zaher et al.
ACTA PHARMACEUTICA (2020)
Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR
Jaegyun Lim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Identification of Coronavirus Isolated from a Patient in Korea with COVID-19
Jeong-Min Kim et al.
OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Clinical trials on drug repositioning for COVID-19 treatment
Sandro G. Viveiros Rosa et al.
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2020)
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
Yang Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity
Yuanmei Zhu et al.
JOURNAL OF VIROLOGY (2019)
Monotherapy with a low-dose lipopeptide HIV fusion inhibitor maintains long-term viral suppression in rhesus macaques
Huihui Chong et al.
PLOS PATHOGENS (2019)
Nucleoside analogues for the treatment of coronavirus infections
Andrea J. Pruijssers et al.
CURRENT OPINION IN VIROLOGY (2019)
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Shuai Xia et al.
SCIENCE ADVANCES (2019)
Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
Maria L. Agostini et al.
JOURNAL OF VIROLOGY (2019)
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
Mart Toots et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
Petter Andersen et al.
VIRUSES-BASEL (2019)
Effects of the Cathepsin K Inhibitor ONO-5334 and Concomitant Use of ONO-5334 with Methotrexate on Collagen-Induced Arthritis in Cynomolgus Monkeys
Hiroyuki Yamada et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2019)
β-D-N4-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome
Nadya Urakova et al.
JOURNAL OF VIROLOGY (2018)
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
Min-Han Lin et al.
ANTIVIRAL RESEARCH (2018)
Exceptional potency and structural basis of a T1249-derived lipopeptide fusion inhibitor against HIV-1, HIV-2, and simian immunodeficiency virus
Yuanmei Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors
Chao Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication
Guido A. Gualdoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo
Hui-Jun Dong et al.
VIRUSES-BASEL (2018)
Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion
Alexandra C. Walls et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis
Glaucia E. Callera et al.
BIOSCIENCE REPORTS (2016)
Fighting viruses with antibiotics: an overlooked path
Philippe Colson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses
Hanjun Zhao et al.
SCIENTIFIC REPORTS (2016)
Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
Jean-Francois Rossingol
JOURNAL OF INFECTION AND PUBLIC HEALTH (2016)
Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus Infection
Liviawati S. Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs
Jianzhong Cao et al.
ANTIVIRAL RESEARCH (2015)
Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean
Saori Takahashi et al.
BIOMEDICAL RESEARCH-TOKYO (2015)
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
Jasper Fuk-Woo Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
The anti-obesity drug orlistat reveals anti-viral activity
Elisabeth Ammer et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
Olivier Reynard et al.
VIRUSES-BASEL (2015)
Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases
Yara Dadalti Fragoso et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2015)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Jean-Francois Rossignol
ANTIVIRAL RESEARCH (2014)
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
Lisa Oestereich et al.
ANTIVIRAL RESEARCH (2014)
Characterization of IIPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class Ill phosphoinositide 3-kinase
Ruzica Bago et al.
BIOCHEMICAL JOURNAL (2014)
Homoharringtonine and omacetaxine for myeloid hematological malignancies
Shuqing Lu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases
Yahira M. Baez-Santos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
Ali S. Omrani et al.
LANCET INFECTIOUS DISEASES (2014)
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo
William E. Dowdle et al.
NATURE CELL BIOLOGY (2014)
Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: Insights into mechanisms of general viral fusion and inhibitor design
Halil Aydin et al.
PROTEIN SCIENCE (2014)
Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments
Vineet D. Menachery et al.
VIRUS RESEARCH (2014)
The Coronavirus Nucleocapsid Is a Multifunctional Protein
Ruth McBride et al.
VIRUSES-BASEL (2014)
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu Lu et al.
NATURE COMMUNICATIONS (2014)
The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
Jared M. Lucas et al.
CANCER DISCOVERY (2014)
Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetine
Wilson Wong et al.
ELIFE (2014)
Clemizole Hydrochloride Is a Novel and Potent Inhibitor of Transient Receptor Potential Channel TRPC5
Julia M. Richter et al.
MOLECULAR PHARMACOLOGY (2014)
Modulation of Fatty Acid Synthase Enzyme Activity and Expression during Hepatitis C Virus Replication
Neda Nasheri et al.
CHEMISTRY & BIOLOGY (2013)
Synthesized Peptide Inhibitors of HIV-1 gp41-dependent Membrane Fusion
Yuxian He
CURRENT PHARMACEUTICAL DESIGN (2013)
Systematic review of clofazimine for the treatment of drug-resistant tuberculosis
M. Gopal et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth
Lei Wang et al.
NATURE COMMUNICATIONS (2013)
Severe Acute Respiratory Syndrome Coronavirus Replication Inhibitor That Interferes with the Nucleic Acid Unwinding of the Viral Helicase
Adeyemi O. Adedeji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
Development of novel entry inhibitors targeting emerging viruses
Yanchen Zhou et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain
Martha Schneider et al.
JOURNAL OF VIROLOGY (2012)
New 3-amidinophenylalanine-derived inhibitors of matriptase
Maya Hammami et al.
MEDCHEMCOMM (2012)
Emodin inhibits current through SARS-associated coronavirus 3a protein
Silvia Schwarz et al.
ANTIVIRAL RESEARCH (2011)
2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)
Mi Kyoung Kim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Crystal Structure and Functional Analysis of the SARS-Coronavirus RNA Cap 2′-O-Methyltransferase nsp10/nsp16 Complex
Etienne Decroly et al.
PLOS PATHOGENS (2011)
Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model
Benelita Tina Elie et al.
BIOCHIMIE (2010)
Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties
Sylvia Deppe et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
Barry R. O'Keefe et al.
JOURNAL OF VIROLOGY (2010)
Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors
I-Jung Liu et al.
ANTIVIRAL RESEARCH (2009)
Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase
Chaewoon Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
High-Throughput Cell-Based Screen for Chemicals That Inhibit Infection by Simian Virus 40 and Human Polyomaviruses
Edward C. Goodwin et al.
JOURNAL OF VIROLOGY (2009)
The pharmacokinetics and interactions of ivermectin in humans - A mini-review
Aranzazu Gonzalez Canga et al.
AAPS JOURNAL (2008)
Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors
Veena Nukoolkarn et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses
Andrew D. Regan et al.
VETERINARY MICROBIOLOGY (2008)
SARS coronavirus replicase proteins in pathogenesis
Rachel L. Graham et al.
VIRUS RESEARCH (2008)
Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway
Makoto Ujike et al.
JOURNAL OF VIROLOGY (2008)
The intracellular sites of early replication and budding of SARS-coronavirus
Silke Stertz et al.
VIROLOGY (2007)
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
Tin-Yun Ho et al.
ANTIVIRAL RESEARCH (2007)
The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport
Anna C. Rutherford et al.
JOURNAL OF CELL SCIENCE (2006)
Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry
Zhaozhu Qiu et al.
JOURNAL OF VIROLOGY (2006)
Understanding helicases as a means of virus control
D. N. Frick et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Viral and cellular RNA helicases as antiviral targets
AD Kwong et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Keynote review:: Progress in targeting HIV-1 entry
HJP Ryser et al.
DRUG DISCOVERY TODAY (2005)
The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus
JA Tanner et al.
CHEMISTRY & BIOLOGY (2005)
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors
SW Liu et al.
LANCET (2004)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
Small molecules targeting severe acute respiratory syndrome human coronavirus
CY Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Severe acute respiratory syndrome coroavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides
BJ Bosch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
New developments in anti-HIV chemotherapy
E De Clercq
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
分享论文
